{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:12:24Z","timestamp":1792239144069,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/bjc.2016.130","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T20:02:30Z","timestamp":1463515350000},"page":"1405-1411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas"],"prefix":"10.1038","volume":"114","author":[{"given":"Kati","family":"K\u00e4mpj\u00e4rvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Netta","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miika","family":"Mehine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salla","family":"V\u00e4lipakka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Uimari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Pitk\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna-Riikka","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Tolvanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ahtikoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Frizzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Sarvilinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri A","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Vahteristo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"BFbjc2016130_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/path.2932","volume":"225","author":"C Bardella","year":"2011","unstructured":"Bardella C, El-Bahrawy M, Frizzell N, Adam J, Ternette N, Hatipoglu E, Howarth K, O'Flaherty L, Roberts I, Turner G, Taylor J, Giaslakiotis K, Macaulay VM, Harris AL, Chandra A, Lehtonen HJ, Launonen V, Aaltonen LA, Pugh CW, Mihai R, Trudgian D, Kessler B, Baynes JW, Ratcliffe PJ, Tomlinson IP, Pollard PJ (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J Pathol 225: 4\u201311.","journal-title":"J Pathol"},{"key":"BFbjc2016130_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-9-20","volume":"9","author":"JP Bayley","year":"2008","unstructured":"Bayley JP, Launonen V, Tomlinson IP (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9: 20.","journal-title":"BMC Med Genet"},{"key":"BFbjc2016130_CR3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","volume":"27","author":"E Bertsch","year":"2014","unstructured":"Bertsch E, Qiang W, Zhang Q, Espona-Fiedler M, Druschitz S, Liu Y, Mittal K, Kong B, Kurita T, Wei JJ (2014) MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol 27: 1144\u20131153.","journal-title":"Mod Pathol"},{"key":"BFbjc2016130_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"D Day Baird","year":"2003","unstructured":"Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188: 100\u2013107.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"BFbjc2016130_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0000000000000573","volume":"40","author":"WJ Harrison","year":"2015","unstructured":"Harrison WJ, Andrici J, Maclean F, Madadi-Ghahan R, Farzin M, Sioson L, Toon CW, Clarkson A, Watson N, Pickett J, Field M, Crook A, Tucker K, Goodwin A, Anderson L, Srinivasan B, Grossmann P, Martinek P, Ondic O, Hes O, Trpkov K, Clifton-Bligh RJ, Dwight T, Gill AJ (2015) Fumarate hydratase-deficient uterine leiomyomas occur in both the syndromic and sporadic settings. Am J Surg Pathol 40 (5): 599\u2013607.","journal-title":"Am J Surg Pathol"},{"key":"BFbjc2016130_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0165-4608(99)00070-9","volume":"115","author":"SE Ingraham","year":"1999","unstructured":"Ingraham SE, Lynch RA, Kathiresan S, Buckler AJ, Menon AG (1999) hREC2, a RAD51-like gene, is disrupted by t(12;14) (q15;q24.1) in a uterine leiomyoma. Cancer Genet Cytogenet 115: 56\u201361.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFbjc2016130_CR7","doi-asserted-by":"publisher","first-page":"E1044","DOI":"10.1002\/ijc.27610","volume":"131","author":"EM Je","year":"2012","unstructured":"Je EM, Kim MR, Min KO, Yoo NJ, Lee SH (2012) Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 131: E1044\u2013E1047.","journal-title":"Int J Cancer"},{"key":"BFbjc2016130_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/humu.22612","volume":"35","author":"K K\u00e4mpj\u00e4rvi","year":"2014","unstructured":"K\u00e4mpj\u00e4rvi K, Park MJ, Mehine M, Kim NH, Clark AD, B\u00fctzow R, B\u00f6hling T, B\u00f6hm J, Mecklin JP, J\u00e4rvinen H, Tomlinson IP, van der Spuy ZM, Sj\u00f6berg J, Boyer TG, Vahteristo P (2014) Mutations in exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat 35: 1136\u20131141.","journal-title":"Hum Mutat"},{"key":"BFbjc2016130_CR9","first-page":"4554","volume":"62","author":"M Kiuru","year":"2002","unstructured":"Kiuru M, Lehtonen R, Arola J, Salovaara R, J\u00e4rvinen H, Aittom\u00e4ki K, Sj\u00f6berg J, Visakorpi T, Knuutila S, Isola J, Delahunt B, Herva R, Launonen V, Karhu A, Aaltonen LA (2002) Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 62: 4554\u20134557.","journal-title":"Cancer Res"},{"key":"BFbjc2016130_CR10","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1073\/pnas.051633798","volume":"98","author":"V Launonen","year":"2001","unstructured":"Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkala E, Sistonen P, Herva R, Aaltonen LA (2001) Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 98: 3387\u20133392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbjc2016130_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10: 397\u2013411.","journal-title":"Fam Cancer"},{"key":"BFbjc2016130_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","volume":"164","author":"R Lehtonen","year":"2004","unstructured":"Lehtonen R, Kiuru M, Vanharanta S, Sj\u00f6berg J, Aaltonen LM, Aittom\u00e4ki K, Arola J, B\u00fctzow R, Eng C, Husgafvel-Pursiainen K, Isola J, J\u00e4rvinen H, Koivisto P, Mecklin JP, Peltom\u00e4ki P, Salovaara R, Wasenius VM, Karhu A, Launonen V, Nupponen NN, Aaltonen LA (2004) Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol 164: 17\u201322.","journal-title":"Am J Pathol"},{"key":"BFbjc2016130_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, Aavikko M, Katainen R, Virolainen E, B\u00f6hling T, Koski TA, Launonen V, Sj\u00f6berg J, Taipale J, Vahteristo P, Aaltonen LA (2011) MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334: 252\u2013255.","journal-title":"Science"},{"key":"BFbjc2016130_CR14","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ijc.28410","volume":"134","author":"N M\u00e4kinen","year":"2014","unstructured":"M\u00e4kinen N, Vahteristo P, B\u00fctzow R, Sj\u00f6berg J, Aaltonen LA (2014) Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas. Int J Cancer 134: 1008\u20131012.","journal-title":"Int J Cancer"},{"issue":"11","key":"BFbjc2016130_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/ejhg.2013.33","volume":"21","author":"N M\u00e4kinen","year":"2013","unstructured":"M\u00e4kinen N, Vahteristo P, K\u00e4mpj\u00e4rvi K, Arola J, B\u00fctzow R, Aaltonen LA (2013) MED12 exon 2 mutations in histopathological uterine leiomyoma variants. Eur J Hum Genet 21 (11): 1300\u20131303.","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"BFbjc2016130_CR16","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski DN, Bartnitzke S, Loning T, Drieschner N, Helmke BM, Bullerdiek J (2012) MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups. Int J Cancer 131 (7): 1528\u20131536.","journal-title":"Int J Cancer"},{"key":"BFbjc2016130_CR17","doi-asserted-by":"publisher","first-page":"e33251","DOI":"10.1371\/journal.pone.0033251","volume":"7","author":"MM McGuire","year":"2012","unstructured":"McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A (2012) Whole exome sequencing in a random sample of north american women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One 7: e33251.","journal-title":"PLoS One"},{"key":"BFbjc2016130_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen H, M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Sarvilinna N, Aavikko M, V\u00e4h\u00e4rautio A, Pasanen A, B\u00fctzow R, Heikinheimo O, Sj\u00f6berg J, Pitk\u00e4nen E, Vahteristo P, Aaltonen LA (2016) Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A 113: 1315\u20131320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFbjc2016130_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, M\u00e4kinen N, Katainen R, K\u00e4mpj\u00e4rvi K, Pitk\u00e4nen E, Heinonen HR, B\u00fctzow R, Kilpivaara O, Kuosmanen A, Ristolainen H, Gentile M, Sj\u00f6berg J, Vahteristo P, Aaltonen LA (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369: 43\u201353.","journal-title":"N Engl J Med"},{"key":"BFbjc2016130_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine M, M\u00e4kinen N, Heinonen HR, Aaltonen LA, Vahteristo P (2014) Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril 102: 621\u2013629.","journal-title":"Fertil Steril"},{"key":"BFbjc2016130_CR21","doi-asserted-by":"publisher","first-page":"34219","DOI":"10.1074\/jbc.M703551200","volume":"282","author":"R Nagai","year":"2007","unstructured":"Nagai R, Brock JW, Blatnik M, Baatz JE, Bethard J, Walla MD, Thorpe SR, Baynes JW, Frizzell N (2007) Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress. J Biol Chem 282: 34219\u201334228.","journal-title":"J Biol Chem"},{"key":"BFbjc2016130_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.08.025","volume":"158","author":"AA Sandberg","year":"2005","unstructured":"Sandberg AA (2005) Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma. Cancer Genet Cytogenet 158: 1\u201326.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFbjc2016130_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","volume":"357","author":"EA Stewart","year":"2001","unstructured":"Stewart EA (2001) Uterine fibroids. Lancet 357: 293\u2013298.","journal-title":"Lancet"},{"key":"BFbjc2016130_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittom\u00e4ki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA Multiple Leiomyoma Consortium (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30: 406\u2013410.","journal-title":"Nat Genet"},{"key":"BFbjc2016130_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0301-2115(98)00204-8","volume":"81","author":"WJ Van de Ven","year":"1998","unstructured":"Van de Ven WJ (1998) Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes. Eur J Obstet Gynecol Reprod Biol 81: 289\u2013293.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BFbjc2016130_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/hmg\/ddi431","volume":"15","author":"S Vanharanta","year":"2006","unstructured":"Vanharanta S, Pollard PJ, Lehtonen HJ, Laiho P, Sj\u00f6berg J, Leminen A, Aittom\u00e4ki K, Arola J, Kruhoffer M, Orntoft TF, Tomlinson IP, Kiuru M, Arango D, Aaltonen LA (2006) Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol Genet 15: 97\u2013103.","journal-title":"Hum Mol Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2016130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2016130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2016130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:32:25Z","timestamp":1684416745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2016130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFbjc2016130"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2016.130","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"assertion":[{"value":"9 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}